Three High-Yield Healthcare Dividend Stocks Worth Holding

Industry
โดย The Motley Fool·Read original
Summary · why it matters

Pfizer, Novo Nordisk, and Sanofi are highlighted as high-yield dividend stocks to buy and hold despite recent challenges. Pfizer offers a forward dividend yield of 7.1% and is expected to benefit from products like Padcev and Abrysvo, along with a promising pipeline in oncology and weight loss. Novo Nordisk, with a 3.6% forward yield, remains a leader in diabetes and weight loss markets and is advancing candidates such as zenagamtide and CagriSema, while also diversifying into rare blood diseases. Sanofi provides a 5.6% forward yield, driven by the strong performance of Dupixent and pipeline prospects like frexalimab, which could generate over $1 billion in peak annual sales.

Impact on stocks 4

Biotech & Genomic Medicine▲ · 3 stocks
Novo Nordisk A/S
NOV
▲ PositiveDemandrelevance

Novo Nordisk remains a leader in diabetes and weight loss markets with advancing candidates and diversification into rare blood diseases.

Pfizer Inc
PFE
▲ PositiveCapitalrelevance

Pfizer offers a high forward dividend yield of 7.1% and is expected to benefit from products like Padcev and Abrysvo, along with a promising pipeline.

Health Care▲ · 1 stocks
Sanofi SA
SAN
▲ PositiveDemandrelevance

Sanofi is driven by strong Dupixent performance and pipeline prospects like frexalimab with potential peak sales over $1 billion.

© 2026 MarketDXNews